Blood Components

Blood Components – Detailed Study Notes

1. Whole Blood

  • Contents:
    • Contains Red Blood Cells (RBCs), plasma, platelets, and clotting factors.
  • Volume:
    • Approximately 450-500 mL.
  • Storage:
    • Maintained at temperatures between 1–6°C.
  • Shelf Life:
    • 21–35 days depending on the type of anticoagulant used.
  • Uses:
    • Rarely used; primarily for trauma cases or massive hemorrhage.

2. Packed Red Blood Cells (PRBCs)

  • Description:
    • Concentrated form of RBCs with most plasma removed.
  • Function:
    • Increases oxygen-carrying capacity in patients.
  • Storage:
    • Kept at 1–6°C.
  • Shelf Life:
    • 42 days when stored with an additive solution.
  • Indications:
    • Anemia and blood loss situations.
  • Expected Increase:
    • Hemoglobin (Hgb) increases by approximately 1 g/dL per unit administered.

3. Leukocyte-Reduced RBCs

  • Description:
    • RBCs that have been filtered to remove White Blood Cells (WBCs).
  • Benefits:
    • Reduces the risk of febrile non-hemolytic transfusion reactions.
    • Prevents Cytomegalovirus (CMV) transmission.
  • Indications:
    • Suitable for chronically transfused patients and immunocompromised individuals.

4. Washed RBCs

  • Description:
    • RBCs washed with saline in order to remove plasma proteins.
  • Components Removed:
    • Immunoglobulin A (IgA) and potential allergens.
  • Indications:
    • Indicated for patients with IgA deficiency or severe allergic reactions.
  • Shelf Life:
    • Limited to 24 hours after the washing process.

5. Irradiated RBCs

  • Procedure:
    • RBCs are exposed to gamma radiation.
  • Purpose:
    • Prevents Graft-Versus-Host Disease (GVHD).
  • Indications:
    • Recommended for immunocompromised patients, transplant recipients, and neonates.
  • Shelf Life:
    • Shortened to 28 days post-irradiation.

6. Platelets

  • Source:
    • Can be derived from whole blood or produced via apheresis technology.
  • Storage Conditions:
    • Kept at 20–24°C with agitation.
  • Shelf Life:
    • 5–7 days.
  • Indications:
    • Treatment for thrombocytopenia and platelet dysfunction.
  • Expected Increase:
    • Apheresis units can increase counts by 30,000–60,000/µL.

7. Fresh Frozen Plasma (FFP)

  • Contents:
    • Composed of all clotting factors.
  • Collection Process:
    • Must be frozen within 8 hours of collection.
  • Storage:
    • Maintained at temperature ≤ -18°C.
  • Shelf Life:
    • One year.
  • Indications:
    • Used for coagulation factor deficiencies, liver disease, and disseminated intravascular coagulation (DIC).
  • Compatibility:
    • Must be ABO compatible with the recipient.

8. Cryoprecipitate

  • Contents:
    • Rich in fibrinogen, Factor VIII, von Willebrand factor (vWF), and Factor XIII.
  • Preparation:
    • Derived from thawed Fresh Frozen Plasma (FFP).
  • Storage:
    • Kept at temperature ≤ -18°C.
  • Shelf Life:
    • One year.
  • Indications:
    • Useful for low fibrinogen levels, DIC, and hemophilia A when no factor is available.

9. Plasma Derivatives

  • Types:
    • Albumin:
    • Used for volume expansion.
    • IVIG (Intravenous Immunoglobulin):
    • Utilized for immune deficiencies.
    • Factor Concentrates:
    • Employed in hemophilia treatment.
  • Manufacturing:
    • Produced from pooled plasma.

10. Compatibility Overview

  • RBCs:
    • Must match both ABO group and Rh factor.
  • Plasma:
    • Donor plasma must be compatible with the recipient's RBCs.
  • Platelets:
    • ABO group matching is preferred, but not strictly required.
  • Cryoprecipitate:
    • No strict ABO requirement.

11. Key Exam Tips

  • PRBCs:
    • Primarily serve for oxygen delivery.
  • Platelets:
    • Essential for bleeding prevention.
  • Fresh Frozen Plasma (FFP):
    • Focuses on providing clotting factors.
  • Cryoprecipitate:
    • Rich in fibrinogen content.
  • Leukoreduction:
    • A method that helps prevent febrile reactions during transfusions.
  • Irradiation:
    • A preventive measure against Graft-Versus-Host Disease (GVHD).